ORAI1 and cervical cancer: Interestingly, the expression of STIM1 and Orai1 was increased in most cervical cancer specimens, while the acetylation of tubulin was decreased [19,20], suggesting that specific targeting of HDAC6 in cervical cancer can inhibit STIM1-Orai1-mediated cervical neogenesis.